Dr. Liu Hongyan is an Associate Chief Physician in the Department of Hematology and Oncology at Beijing Jingdu Children’s Hospital, a leading institution specializing in pediatric hematologic and oncologic care. With 15 years of clinical experience, she has dedicated her career to advancing treatments for childhood blood disorders and cancers.
Dr. Liu began her medical journey at Henan University, where she earned her bachelor’s degree, followed by a Master’s in Pediatrics from Guangxi Medical University in 2010 . Her early career included a tenure at the former Beijing Armed Police General Hospital’s Pediatric Department, where she was recognized with the Outstanding Physician Award for her clinical excellence . Since joining Beijing Jingdu Children’s Hospital, she has become a cornerstone of its hematology team, focusing on high-risk leukemia, lymphoma, and bone marrow failure syndromes.
Dr. Liu specializes in diagnosis and management of pediatric hematologic malignancies and benign blood disorders:
1. Pediatric hematology oncology:
2. Specialized in the diagnosis and treatment of pediatric hematological oncology, including neuroblastoma, hepatoblastoma, nephroblastoma, rhabdomyosarcoma, and retinoblastoma.
3. Leukemia & Lymphoma:
Acute lymphoblastic leukemia (ALL): Risk-stratified chemotherapy and relapse prevention
Refractory lymphoma: Salvage regimens and immunotherapy integration
4. Bone Marrow Failure Syndromes:
Severe aplastic anemia: Immunosuppressive therapy (IST) and hematopoietic stem cell transplantation (HSCT) coordination
Myelodysplastic syndromes (MDS): Diagnostic workup and transfusion support
5. Supportive Care:
Management of chemotherapy-induced complications (e.g., neutropenia, thrombocytopenia)
Member of the First Committee of the Rare Disease Oncology Branch of the China Rare Disease Alliance
Member, Pediatric Hematology-Oncology Committee
Participating Editor, National Pediatric Hematology Guidelines
Member of the Pediatric Oncology Special Committee of the Chinese Research Hospital Association
Member of the Precision Treatment of Pediatric Oncology Special Committee of the Chinese Biomedical Engineering Society
Member of the Integrated Rehabilitation Professional Committee for Pediatric Oncology of the Chinese Anti-Cancer Association
Council Member of the Integrated Oncology Professional Committee of the World Federation of Chinese Medicine Societies (WFCMS)
Henan University (undergraduate program)
Master’s Degree in Pediatrics, Guangxi Medical University
Specialized in pediatric hematology and oncology during her tenure at Beijing Armed Police General Hospital
Advanced workshops on chemotherapy protocols and supportive care for pediatric cancer patients (inferred from career trajectory)
While detailed research outputs are not publicly documented, her clinical contributions suggest engagement in:
Chemotherapy Optimization: Tailoring protocols for reduced toxicity in pediatric populations
Survivorship Studies: Long-term follow-up of leukemia survivors to address endocrine and cognitive sequelae
Guideline Development: Contributions to national pediatric hematology treatment algorithms
Chinese (Mandarin) and English
Her academic contributions likely include:
Co-authorship in institutional clinical guidelines or textbook chapters (inferred from her role as a participating editor)
Conference Abstracts: Presentations at national pediatric hematology conferences (topics unspecified)
Outstanding Physician Award and long-term clinical tenure suggest strong patient trust .
Inferred strengths from clinical peers: Empathetic communication, meticulous treatment planning, and collaborative decision-making.
EN
CN
